Neuropeptide Y Y-1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation

被引:30
作者
Racchi, H
Schliem, AJ
Donoso, MV
Rahmer, A
Zuniga, A
Guzman, S
Rudolf, K
HuidobroToro, JP
机构
[1] PONTIFICIA UNIV CATOLICA CHILE,DEPT PHYSIOL,FAC BIOL SCI,SANTIAGO,CHILE
[2] PONTIFICIA UNIV CATOLICA CHILE,SCH MED,DEPT DIGEST SURG,SANTIAGO,CHILE
[3] DR KARL THOMAE GMBH,DIV PHARMA RES,D-88397 BIBERACH,GERMANY
关键词
BIBP; 3226; neuropeptide Y receptor; neuropeptide Y Y-1 receptor; sympathetic stimulation; mesenteric artery; human; inferior; mesenteric vein;
D O I
10.1016/S0014-2999(97)00160-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuropeptide Y, a novel neurotransmitter, interacts with selective membrane receptors to cause vasoconstriction. Frequency- and concentration-dependent isometric contractions were observed in human inferior mesenteric artery and vein mounted rings that were stimulated with either electrical pulses (70 V, 0.5 ms, 2.5-20 Hz) or noradrenaline. The antagonism elicited by 100 nM tetrodotoxin and 1 mu M guanethidine confirmed the neuronal and sympathetic origins of the vasomotor response. Incubation with BIBP 3226 ((R)-N-2-(diphrnacetyl)-N-(4-hydroxyphenyl)-methyl-D-arginineamide), a selective neuropeptide Y Y, receptor antagonist, significantly reduced the vasoconstriction. The incomplete antagonist activity of BIBP 3226 tends to support the hypothesis of sympathetic co-transmission involving neuropeptide Y, adenosine 5'-triphosphate and noradrenaline. These findings were confirmed in parallel studies using rat superior mesenteric artery and vein ring preparations. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 17 条
[1]  
CLARKE JG, 1987, LANCET, V1, P1057
[2]  
DONOSO MV, 1997, IN PRESS J NEUROCHEM, V68
[3]  
DOODS HN, 1995, J PHARMACOL EXP THER, V275, P136
[4]   NEUROPEPTIDE-Y POTENTIATES THE EFFECT OF VARIOUS VASOCONSTRICTOR AGENTS ON RABBIT-BLOOD VESSELS [J].
EDVINSSON, L ;
EKBLAD, E ;
HAKANSON, R ;
WAHLESTEDT, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (02) :519-525
[5]   NEUROPEPTIDE-Y MODULATES THE ACTION OF VASODILATOR AGENTS IN GUINEA-PIG EPICARDIAL CORONARY-ARTERIES [J].
GULBENKIAN, S ;
EDVINSSON, L ;
OPGAARD, OS ;
VALENCA, A ;
WHARTON, J ;
POLAK, JM .
REGULATORY PEPTIDES, 1992, 40 (03) :351-362
[6]   PEPTIDERGIC INNERVATION OF HUMAN EPICARDIAL CORONARY-ARTERIES [J].
GULBENKIAN, S ;
OPGAARD, OS ;
EKMAN, R ;
ANDRADE, NC ;
WHARTON, J ;
POLAK, JM ;
MELO, JQE ;
EDVINSSON, L .
CIRCULATION RESEARCH, 1993, 73 (03) :579-588
[7]  
LOPEZ LF, 1989, PEPTIDES, V10, P551
[8]   INHIBITION OF SYMPATHETIC VASOCONSTRICTION IN PIGS IN-VIVO BY THE NEUROPEPTIDE Y-Y-1 RECEPTOR ANTAGONIST BIBP-3226 [J].
LUNDBERG, JM ;
MODIN, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (07) :2971-2982
[9]   NEUROPEPTIDE Y-INDUCED PRESSOR-RESPONSES - ACTIVATION OF A NON-ADRENERGIC MECHANISM, POTENTIATION BY RESERPINE AND BLOCKADE BY NIFEDIPINE [J].
MABE, Y ;
TATEMOTO, K ;
HUIDOBROTORO, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 116 (1-2) :33-39
[10]   NEUROPEPTIDE Y (NPY) - A CORONARY VASOCONSTRICTOR AND POTENTIATOR OF CATECHOLAMINE-INDUCED CORONARY CONSTRICTION [J].
MACHO, P ;
PEREZ, R ;
HUIDOBROTORO, JP ;
DOMENECH, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 167 (01) :67-74